Results from phase I dose escalation of IMC-F106C, the first PRAME X CD3 ImmTAC bispecific protein in solid tumors Meeting Abstract
| Authors: | Hamid, O.; Sato, T.; Davar, D.; Callahan, M. K.; Thistlethwaite, F.; Aljumaily, R.; Johnson, M. L.; Arkenau, H. T.; Ileana Dumbrava, E. E.; Izar, B.; Chen, H. A.; Marshall, S.; Yuan, Y.; Deo, M.; Stanhope, S.; Collins, L.; Mundy, R.; Abdullah, S. E.; Lopez, J. S. |
| Abstract Title: | Results from phase I dose escalation of IMC-F106C, the first PRAME X CD3 ImmTAC bispecific protein in solid tumors |
| Meeting Title: | ESMO Congress 2022 |
| Journal Title: | Annals of Oncology |
| Volume: | 33 |
| Issue: | Suppl. 7 |
| Meeting Dates: | 2022 Sep 9-13 |
| Meeting Location: | Paris, France |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2022-09-01 |
| Start Page: | S875 |
| Language: | English |
| ACCESSION: | WOS:000866211600716 |
| DOI: | 10.1016/j.annonc.2022.07.854 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 728O -- Source: Wos |
